Literature DB >> 3380222

Renal hypouricemia due to an isolated renal defect of urate transport.

I Hisatome1, K Ogino, M Saito, J Miyamoto, J Hasegawa, H Kotake, H Mashiba, S Nakamoto.   

Abstract

A 22-year-old man was found to have low serum urate concentration (1.1-1.7 mg/dl). His urate clearance was markedly increased (26.9-35.5 ml/min) and was not decreased after administration of pyrazinamide, but was even more increased after administration of benzbromarone. No other renal tubular abnormalities were detected. The young man has one sister and two brothers. His sister also has hypouricemia and hyperuricosuria. We suggest that the present case had a genetically determined renal abnormality affecting tubular presecretory reabsorption of urate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3380222     DOI: 10.1159/000184991

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  5 in total

Review 1.  Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease.

Authors:  Atsushi Enomoto; Hitoshi Endou
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

2.  Normal serum uric acid concentrations for age and sex and incidence of renal hypouricaemia in Japanese school children.

Authors:  T Igarashi
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

Review 3.  Renal urate handling: clinical relevance of recent advances.

Authors:  Naohiko Anzai; Atsushi Enomoto; Hitoshi Endou
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

4.  Acute renal failure due to uric acid nephropathy in a patient with renal hypouricemia.

Authors:  C M Erley; R R Hirschberg; W Hoefer; K Schaefer
Journal:  Klin Wochenschr       Date:  1989-03-01

Review 5.  Hypouricemia: what the practicing rheumatologist should know about this condition.

Authors:  Carlos Pineda; Carina Soto-Fajardo; Jaime Mendoza; Jessica Gutiérrez; Hugo Sandoval
Journal:  Clin Rheumatol       Date:  2019-10-24       Impact factor: 2.980

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.